PharmiWeb.com - Global Pharma News & Resources
03-Nov-2022

Orthobiologics Market Demand To Reach USD 6.5 billion By 2027 | Future Market Insights

The orthobiologics market demand is anticipated to increase at a CAGR of 3.5% and reach US$ 6.5 billion by 2027.

Furthermore, developments taking place in the market, various trends impacting the performance of the market and other drivers fuelling revenue growth of the global orthobiologics market are enumerated in this elaborate research study.

Certain challenges that are pulling market growth southward are also assessed in this report. The report presents a high-level overview of the global orthobiologics market to the reader and extends support in planning future moves by portraying an accurate forecast model of the global orthobiologics market.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-786

Global Orthobiologics Market: Highlights on Different Segments

The global market for orthobiologics is segmented by product type, by end user and by region.

  • By region, North America is expected to be a highly lucrative market for orthobiologics. Several advancements in healthcare along with rising expenditure on research and development in this region are key parameters pushing the growth of the market upward. The orthobiologics market in North America is expected to reach a value over US$ 3 Bn by the end of the forecast period. The orthobiologics market in Asia Pacific excluding Japan (APEJ) is projected to rise at a higher CAGR of 4.4% during the period of forecast.
  • By end user, the hospitals and ambulatory surgical centres segments are expected to grow at the same pace during the forecast period. However, with respect to revenue, hospitals are a more lucrative option for orthobiologics manufacturers as they have reflected higher demand over the last few years. Orthopaedic clinics are also expected to witness significant growth and register a CAGR of 3.6% during the period of assessment.
  • By product type, the bone graft stimulators segment is the largest and is estimated to reach a market valuation of more than US$ 3 Bn by the end of 2027. Viscosupplements segment is the second largest and a highly lucrative segment expected to witness a higher pace of growth during the forecast period.

Global Orthobiologics Market: Growth Influencing Factors

Factors such as rising incidence of orthopaedic disorders leading to fractures, increasing incidence of sports injuries, rising adoption of orthobiologics material, rising demand for out-patient surgical procedures, increasing demand for orthopaedic surgeries owing to medical tourism and rising technological developments to enhance surgery time and efficiency are supporting the growth of the global orthobiologics market.

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-786

But the market is not void of challenges. High cost of orthopaedic surgery, increasing competition causing price fluctuations, lack of awareness, uncertainty about efficacy, availability of alternative therapies and issues related to devices are posing restraints to the growth of the global orthobiologics market.

Global Orthobiologics Market: Competitive Assessment

The research report on the global orthobiologics market delivers a complete package of market intelligence by covering the analysis on participants in the market. Major companies profiled in this research report include:

Medtronic plc., NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Orthofix International N.V., Anika Therapeutics, Inc., DePuy Synthes (Johnson & Johnson), Bioventus, Arthrex, Inc., SeaSpine Holdings Corporation, Sanofi-Aventis (Sanofi SA), Djo Global, Inc., Seikagaku Corporation, RTI Surgical, Inc., Heraeus Holding GmbH, Fidia Pharma USA Inc., TRB Chemedica International SA, Allosource, Musculoskeletal Transplant Foundation, Inc., and Ito Co., Ltd.

Speak to our Research Expert @ https://www.futuremarketinsights.com/askus/rep-gb-786

Market segmentation The global orthobiologics market is segmented in detail so as to cover every aspect of the market and present a complete market intelligence in front of the reader.

By Product Type

  • Bone Growth Stimulators (BGS)
    • Non-Invasive Electrical BGS
    • Invasive Electrical BGS
    • Ultrasound BGS
  • Viscosupplements
    • Single Injection Viscosupplements
    • Three Injection Viscosupplements
    • Five Injection Viscosupplements
  • Bone Graft Substitute
    • Allografts
    • Synthetics
    • Xenografts
    • Bone Morphogenetic Protein

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East and Africa (MEA)

Top Related Reports Healthcare Market Insights

http://www.renexus.org/network/read-blog/91069

http://redonion.social/read-blog/4052

https://tiptopface.com/read-blog/962

https://forum.leblogger.fr/post/grand-master-brand-now-carries-our-new-exclusive-line-of-animal-foods-our-b–636269e53ef40d1acdcd9526

https://bicycle.one/read-blog/4751

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

Editor Details

Last Updated: 03-Nov-2022